Author:
Chen Xindong,Zhou Zhiruo,Zhang Zhi,Zhao Chenhao,Li Jiayu,Jiang Jingwen,Huang Biao,Qin Yuan
Abstract
Puerarin is a flavonoid molecule that widely exists in various plants. Puerarin has been reported to exhibit anti-tumor effects in various cancers. However, its exact underlying pharmacological mechanism is unclear. This study evaluated the anticancer effect of puerarin combined with oxaliplatin (OXA) in vitro and in vivo. Our results indicated that puerarin can reverse platinum-based anti-cancer drug resistance, and enhance the OXA’s anticancer effects on breast cancer. Furthermore, puerarin can inhibit migration and reverse the epithelial-mesenchymal transition (EMT) induced by low-dose OXA. Further studies showed that the carbonic anhydrase (CA) XII is a potential target of puerarin. In conclusion, puerarin is expected to become an adjuvant chemotherapy drug and potentially become one of the medicated foods for breast cancer patients.
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Isoflavones derived from plant raw materials: Bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation;Aboushanab;Crit. Rev. Food Sci. Nutr.,2021
2. Molecular mechanisms of anticancer activities of puerarin;Ahmad;Cancer Manag. Res.,2020
3. Flavonoids as anticancer therapies: A systematic review of clinical trials;Bisol;Phytother. Res.,2020
4. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells;Chen;Cancer Lett.,2009
5. In vitro and in vivo antitumour activities of puerarin 6″-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway;Chen;Pharm. Biol.,2016
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献